Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
30th European Congress on Obesity (ECO 2023)
Change in Fibrosis-4 Index (FIB4) over time is associated with subsequent risk of liver events, cardiovascular events, and all-cause mortality in people with obesity and/or type 2 diabetes (T2D)
30th European Congress on Obesity (ECO 2023)